Ivan P. Gergel
Overview
Ivan P. Gergel received an average of $3M in total compensation, including $497K in salary, at Nektar Therapeutics between 2014 and 2015.
Source: SEC filing on April 29, 2016.
Related executives
We found 20 more executives who work or worked at Nektar Therapeutics.
Howard Robin
Nektar Therapeutics
Chief Executive Officer
Gil Labrucherie
Nektar Therapeutics
Chief Financial Officer
Jonathan Zalevsky
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
John Northcott
Nektar Therapeutics
Senior Vice President and Chief Commercial Officer
Mark Wilson
Nektar Therapeutics
General Counsel
Jillian Thomsen
Nektar Therapeutics
Chief Accounting Officer
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
Maninder Hora
Nektar Therapeutics